top of page


£109 (112 tablets)

weight management medication


Mysimba is indicated, as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients.


Objectives of treatment

This treatment is used to reduce the Body Mass Index (BMI) in obese patients (BMI 30+) or in overweight patients (BMI of 27-30) with one or more weight-related co-morbidities.

Who is this treatment available to?

  • Patients aged between 18 and 65 years.

  • Patients with an initial BMI of 30 or greater.

  • Patients with an initial BMI of 27 or greater in the presence of at least one weight-related comorbidity such as:

̵ Controlled Hypertension (High blood pressure)

̵ Dyslipidaemia (abnormal amount of lipids - 'bad' cholesterol in your blood.

̵ Obstructive sleep apnoea

̵ Type 2 diabetes mellitus

This treatment is only available ages between 18 and 65 years.

Furthermore, Any Cancellation within 48 hours prior to appointment will incur a charge of 20% of total service cost.

bottom of page